CCG
ABBV icon

Coastwise Capital Group’s AbbVie ABBV Stock Holding History

Coastwise Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$419K Sell
1,666
-191
-10% -$41.1K 0.24% 84
2026
Q1 		$404K Buy
1,857
+1
+0.1% +$222 0.22% 86
2025
Q4 		$424K Buy
1,856
+81
+5% +$18.5K 0.21% 94
2025
Q3 		$411K Buy
1,775
+41
+2% +$8.35K 0.29% 77
2025
Q2 		$322K Buy
1,734
+11
+0.6% +$2.04K 0.26% 86
2025
Q1 		$361K Sell
1,723
-58
-3% -$11.3K 0.3% 78
2024
Q4 		$316K Buy
1,781
+12
+0.7% +$2.21K 0.25% 89
2024
Q3 		$349K Buy
1,769
+294
+20% +$54.9K 0.29% 87
2024
Q2 		$253K Buy
1,475
+101
+7% +$16.7K 0.24% 94
2024
Q1 		$250K Buy
1,374
+9
+0.7% +$1.55K 0.23% 102
2023
Q4 		$212K Buy
+1,365
New +$199K 0.22% 105
2023
Q1 		– Sell
-1,750
Closed -$283K – 112
2022
Q4 		$283K Sell
1,750
-81
-4% -$12.4K 0.34% 86
2022
Q3 		$246K Buy
1,831
+12
+0.7% +$1.72K 0.39% 80
2022
Q2 		$279K Sell
1,819
-109
-6% -$16.7K 0.34% 81
2022
Q1 		$312K Buy
+1,928
New +$280K 0.39% 73

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Coastwise Capital Group's ABBV Position: Q2 2026 in Review

Coastwise Capital Group reduced its AbbVie (ABBV) stake by 10% in Q2 2026, selling an estimated $41.1K and leaving 1,666 shares worth $419K. The position accounts for 0.24% of the portfolio, ranked #84.

Coastwise Capital Group first reported a position in ABBV in Q1 2022 and has held it in 15 quarters since. The position peaked at $424K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Coastwise Capital Group held 1,666 shares of AbbVie worth $419K as of Q2 2026.
  • Coastwise Capital Group sold 191 AbbVie shares in Q2 2026, an estimated $41.1K.
  • AbbVie made up 0.24% of Coastwise Capital Group's portfolio in Q2 2026, its #84 holding.
  • Coastwise Capital Group first reported a position in AbbVie in Q1 2022 and has held it in 15 quarters since.
  • Coastwise Capital Group's AbbVie position peaked at $424K in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.